Related by context. All words. (Click for frequent words.) 74 neuroblastoma 74 ependymoma 72 glioblastoma 71 medulloblastomas 70 rhabdomyosarcoma 68 synovial sarcoma 67 acute lymphoblastic leukemia 67 Wilms tumor 67 leukemia ALL 66 neuroblastomas 66 lymphomas 66 acute myeloid leukemia 65 sarcomas 65 tumors 65 glioblastomas 65 WT1 65 NF1 65 Neuroblastoma 65 Glioblastoma 65 astrocytoma 65 Ewing sarcoma 64 ovarian tumors 64 gliomas 64 GISTs 64 Burkitt lymphoma 64 glioblastoma multiforme GBM 64 primitive neuroectodermal tumors 64 hepatoblastoma 63 brain tumors 63 BRAF gene 63 NF2 63 lymphoblastic leukemia 63 angiosarcoma 63 tumor 63 retinoblastoma 63 acute myelogenous leukemia AML 63 ependymomas 63 oncogenes 62 metastasis 62 Medulloblastoma 62 DIPG 62 leukaemias 62 sporadic ALS 62 glioma 62 astrocytomas 62 Hedgehog pathway 62 IDH2 62 JMML 62 lung tumors 61 Acute Lymphoblastic Leukemia 61 chronic granulomatous disease 61 myeloma cells 61 leukemia 61 familial ALS 61 malignant tumors 61 FLT3 61 acute lymphoblastic 61 Glioma 61 EGFR gene 61 Glioblastomas 61 mitochondrial dysfunction 61 EGFRvIII 61 leukemic cells 61 metastatic cancer 61 sarcoma 61 acute leukemia 61 leukemias 61 paraganglioma 61 breast tumors 61 tumor suppressor gene 61 Six3 61 neuroendocrine tumors 61 hepatocellular carcinoma HCC 61 Fanconi anemia 61 acute leukemias 60 embryonal rhabdomyosarcoma 60 pancreatic tumors 60 endostatin 60 acute myeloid leukemia AML 60 oncogenic 60 mutant protein 60 alveolar rhabdomyosarcoma 60 acute lymphocytic leukemia 60 mutated genes 60 MYCN amplification 60 BCR ABL 60 Acute lymphoblastic leukemia 60 oncogene 60 GIST tumors 60 leukemia AML 60 glioblastoma multiforme 60 basal cell carcinomas 60 gastrointestinal stromal tumor 60 gastrointestinal stromal tumors 60 Glioblastoma multiforme GBM 60 medulloblastoma tumors 60 leiomyosarcoma 60 pancreatic adenocarcinoma 60 melanoma 60 Angelman syndrome 60 malignant brain 60 Rhabdomyosarcoma 60 CDK4 60 Glioblastoma multiforme 60 SOD1 60 Acute Myelogenous Leukemia 60 carcinoid tumors 60 malignancies 60 Foxp3 60 juvenile myelomonocytic leukemia 60 parainfluenza virus 60 Osteosarcoma 60 TGF beta 60 breast carcinomas 59 Acute Leukemia 59 beta thalassemia 59 tyrosine kinase inhibitors 59 GBM tumors 59 carcinoma 59 follicular lymphoma 59 metastatic melanoma 59 Glioblastoma Multiforme 59 lymphoblastic lymphoma 59 CLL 59 solid tumors 59 tumor suppressor genes 59 Gleevec resistant 59 malignancy 59 cell lymphomas 59 hedgehog pathway 59 oligodendrogliomas 59 metastases 59 oncogenesis 59 Lafora disease 59 osteosarcoma 59 grade gliomas 59 GRP# 59 acute promyelocytic leukemia 59 TAp# 59 EGFR 59 miR #b [001] 59 JAK2 59 cancers 59 ADPKD 59 HER2/neu 59 anaplastic 59 metastatic tumors 59 PDGFRA 59 cell acute lymphoblastic 59 epithelial cancers 59 malignant transformation 59 HGPS 59 MALT lymphoma 59 thymoma 59 basal cell carcinoma BCC 59 acute lymphoid leukemia 59 lymphoid 59 Cholangiocarcinoma 59 chronic myelogenous leukemia CML 59 lymphoma 59 Gliomas 59 MGUS 59 liver metastases 59 RSV infection 59 myeloid 59 Akt1 59 neuroblastoma cells 58 childhood leukemias 58 PCNSL 58 uPAR 58 TGF β 58 EGF receptor 58 neurofibromatosis type 58 squamous cell lung cancer 58 VHL gene 58 leukemias lymphomas 58 p# gene 58 recurrent glioblastoma 58 osteosarcomas 58 HCV infection 58 overexpress 58 Hurler syndrome 58 Prox1 58 basal cell nevus syndrome 58 glioblastoma tumors 58 chronic lymphocytic leukemia CLL 58 LRRK2 58 pancreatic tumor 58 uveal melanoma 58 DiGeorge syndrome 58 neurodegenerative disorder 58 aneuploidy 58 pancreatic cancers 58 hepatocellular carcinoma 58 JAK2 gene 58 CMV infection 58 gastrointestinal stromal tumor GIST 58 Acute Lymphocytic Leukemia 58 Rett syndrome 58 tumor recurrence 58 gastrointestinal stromal tumors GISTs 58 tyrosine kinases 58 EGFr 58 NF kB pathway 58 NOTCH1 58 oncoprotein 58 renal cell carcinoma 58 alpha synuclein gene 58 epithelial tumors 58 mutated gene 58 neuroblastoma tumors 58 diffuse intrinsic pontine glioma 58 sarcomatoid 58 AAV2 58 lymphocytes 58 adenocarcinoma 58 Dr. Victor Velculescu 58 TTR gene 58 ovarian cancers 58 hypereosinophilic syndrome 58 overexpression 58 fusion protein 58 Anaplastic 58 MECP2 gene 58 hypermethylation 58 leukemia CLL 58 GBMs 58 gastric carcinoma 58 microRNA miR 58 prostate tumor 58 PARP inhibition 58 DLX5 58 carcinoid cancer 58 Acute Myelogenous Leukemia AML 58 leukemic stem cells 57 mutations 57 PKCi 57 cranial radiation 57 Acute Lymphoblastic Leukaemia 57 CD# [002] 57 clusterin 57 IDH1 57 dyskeratosis congenita 57 CLL cells 57 bladder cancers 57 carcinoid 57 proto oncogene 57 TET2 57 MELAS 57 PNET 57 Skp2 57 pilocytic astrocytoma 57 GSTP1 57 cyclin E 57 pilocytic astrocytomas 57 myeloproliferative disorders 57 subtype 57 hTERT 57 PIK3CA 57 B lymphocytes 57 Glioblastoma Multiforme GBM 57 myeloproliferative diseases 57 BRAF mutations 57 colorectal tumors 57 Rb gene 57 APOL1 57 chromosomal translocations 57 cisplatin resistant 57 NKX2 57 autosomal recessive 57 malignant lymphoma 57 HbF 57 holoprosencephaly 57 metastatic lung cancer 57 metastatic lesions 57 Niemann Pick disease 57 nonsense mutations 57 mesotheliomas 57 Follicular lymphoma 57 chromosome abnormality 57 histiocytosis 57 P. falciparum 57 brain metastases 57 PTEN gene 57 Wnt signaling pathway 57 lung adenocarcinoma 57 interferon pathway 57 myotonic dystrophy 57 Epstein Barr virus EBV 57 blastoma 57 teratoma 57 breast cancers 57 GSK3 57 malignant melanoma 57 epigenetic mechanisms 57 Kabuki syndrome 57 Notch1 57 p# mutations 57 primitive neuroectodermal tumor 57 gastric cancers 57 PARP inhibitors 57 beta1 integrin 57 gene mutations 57 cyclin D1 57 IGF 1R 57 EGFR inhibitors 57 gene amplification 57 adenocarcinomas 57 activating mutations 56 BCL#A 56 BMP4 56 papillary thyroid cancer 56 oligodendroglioma 56 prostate tumors 56 Non Hodgkin lymphoma 56 mitochondrial disease 56 Wegener granulomatosis 56 LRRK2 gene 56 HDAC 56 recurrent glioblastoma multiforme 56 huntingtin gene 56 papillary RCC 56 glioma cells 56 mouse neural stem 56 neurofibromas 56 LIS1 56 Plasmodium falciparum 56 familial pancreatic cancer 56 prostate adenocarcinoma 56 NPM1 56 tuberous sclerosis 56 STAT4 56 NKX#.# 56 BRAF V#E 56 Friedreich ataxia 56 PDGFR 56 essential thrombocythemia 56 acute myelogenous leukemia 56 multidrug resistance 56 Ets2 56 micro RNAs 56 neuroblastoma tumor 56 MDM2 56 genetic abnormalities 56 FTLD 56 RDEB 56 chromosomal translocation 56 metastatic melanomas 56 FSGS 56 Hedgehog signaling pathway 56 pheochromocytoma 56 familial hypercholesterolemia 56 Smad3 56 frontotemporal dementia 56 bone marrow stem cells 56 molecular abnormalities 56 EGFR mutations 56 neoplastic cells 56 immunodeficiency 56 Epstein Barr virus 56 lung adenocarcinomas 56 breast cancer metastasis 56 inherited mutations 56 Waldenstrom macroglobulinemia 56 melanoma tumors 56 neural crest 56 IKZF1 56 gene mutation 56 herpes viruses 56 Li Fraumeni syndrome 56 nonsense mutation 56 myeloid cells 56 Wwox 56 JAK3 56 STAT3 56 chromosomal defect 56 Duchenne muscular dystrophy DMD 56 Dravet syndrome 56 neuroendocrine cancers 56 KIT mutations 56 neural cells 56 factor receptor 56 ARVD 56 subependymal giant cell 56 premalignant 56 imatinib 56 renal cell carcinomas 56 Burkitt Lymphoma 56 JAK2 enzyme 56 MeCP2 gene 56 Smad7 56 palladin 56 meningioma 56 relapsing remitting 56 GNAQ 56 micro RNA 56 DFMO 56 neurofibromatosis 56 myelogenous leukemia 56 pDCs 56 medullary thyroid cancer 56 cardiac hypertrophy 56 Cyclin D1 56 myelofibrosis 56 Hodgkin Lymphoma 56 myeloid leukemia 56 SOD1 gene 56 c myc 56 Stat5 56 ZNF# 56 B7 H1 56 atypical hemolytic uremic syndrome 56 TERT 56 colorectal carcinoma 56 mammary cells 56 pleural mesothelioma 56 tumor suppressors 56 serotonin receptor 56 EGFR protein 56 Retinoblastoma 56 HCMV 56 malignant pleural mesothelioma 56 hypophosphatasia 56 NFkB 56 Wilm Tumor 56 lobular carcinoma 56 TMEM#B 56 heavily pretreated 56 BRAF mutation 56 papillary carcinoma 55 lung metastasis 55 CXCR4 55 CDH1 55 c Myc 55 colorectal tumor 55 cholangiocarcinoma 55 Ewing Sarcoma 55 EoE 55 miR #a [002] 55 tumor antigen 55 MUC1 55 grade cervical intraepithelial 55 renal carcinoma 55 protein encoded 55 KRAS gene 55 K ras mutations 55 Cryptococcus neoformans 55 autosomal dominant 55 biliary atresia 55 Kufs disease 55 beta globin gene 55 Wilms Tumor 55 bronchopulmonary dysplasia 55 dasatinib 55 diffuse pontine glioma 55 synaptogenesis 55 miRs 55 E#F# 55 metastatic 55 mammary tumors 55 mtDNA mutations 55 breast carcinoma 55 genetic alteration 55 Wnt signaling 55 chromosomal rearrangement 55 NKT cells 55 HER2 positive breast cancer 55 Leukemias 55 genetic abnormality 55 Th2 cells 55 S#A# [002] 55 VEGFR2 55 malignant cells 55 vimentin 55 myelodysplasia 55 EZH2 55 grade glioma 55 imatinib resistant 55 Chronic lymphocytic leukemia 55 colon carcinoma 55 leukaemic cells 55 HDACs 55 atherosclerotic lesions 55 BCR ABL protein 55 gastric cancer 55 Acute Myeloid Leukemia 55 monogenic 55 chronic eosinophilic leukemia 55 Immunohistochemical analysis 55 CHD7 55 micrometastases 55 lymphangiogenesis 55 anaplastic astrocytoma 55 Joubert syndrome 55 autoantibodies 55 serous ovarian cancer 55 mitochondrial disorders 55 Peutz Jeghers syndrome 55 E cadherin 55 severe aplastic anemia 55 mutation 55 histone deacetylases 55 S. pneumoniae 55 haematopoietic 55 colon cancers 55 chemoresistance 55 androgen receptor AR 55 malignant pancreatic 55 IDH1 mutations 55 isoform 55 genetic alterations 55 activin 55 IDH1 mutation 55 STK# [002] 55 nonsmall cell lung cancer 55 neoplasm 55 chromosomal aberrations 55 Pten 55 FUS1 55 tumor cells 55 Hashimoto thyroiditis 55 T#I [002] 55 lymphocytic leukemia 55 cardiac fibroblasts 55 p# tumor suppressor 55 tyrosine kinase 55 transgenic mice 55 MYCN 55 protein kinases 55 ALK mutations 55 spinal muscular atrophy SMA 55 lung cancers 55 Myc 55 CMV disease 55 chronic myeloid leukemia CML 55 TOP2A 55 desmoplastic 55 MLL gene 55 Philadelphia Chromosome Positive 55 alternatively spliced 55 Src 55 aneuploid cells 55 NF1 gene 55 polyomavirus 55 HDAC inhibitors 55 FGFR1 55 TP# gene 55 ccRCC 55 PGE2 55 mesenchymal cells 55 nucleoside analogues 55 mosaicism 55 V#F mutation 55 missense mutations 55 CD# mAb 55 bcl 2 55 Flt3 55 MDSCs 55 HER2 receptor 55 squamous cell carcinoma SCC 55 mycosis fungoides 55 measles virus 55 multiple myeloma 55 Her-2/neu 55 papillary renal cell carcinoma 55 interleukins 55 ADAM# 55 T#I mutant 55 autologous transplants 55 Wilm tumor 55 smoldering myeloma 55 PTPN# 55 pancreatic ductal adenocarcinoma 55 nestin 55 C EBP alpha 55 NPHP 55 iNOS 55 DNA methylation 54 E cadherin expression 54 cancer 54 B7 H3 54 menin 54 tumor progression 54 MLH1 54 neutralizing antibodies 54 allogeneic bone marrow 54 JAK mutations 54 thyroid cancers 54 liver metastasis 54 myelodysplastic syndrome MDS 54 Plasmodium 54 hemophagocytic lymphohistiocytosis 54 neoplastic 54 miRNAs 54 cytokine IL 54 adenoma 54 Meningiomas 54 cultured cells 54 Velculescu 54 osteopontin 54 Akt 54 glomerulonephritis 54 TNF alpha 54 cytomegalovirus CMV 54 autoimmune disease 54 mutational status 54 survivin 54 basal cell carcinoma 54 G#S mutation 54 tumor suppressor protein 54 tuberous sclerosis complex 54 Hirschsprung disease 54 PTLD 54 ovarian cancer 54 IGFBP2 54 Chronic Lymphocytic Leukemia CLL 54 autoinflammatory diseases 54 histologic subtype 54 neurotrophin 54 pDC 54 seminoma 54 constitutively active 54 invasive ductal 54 FGFR2 54 MSH2 54 renal fibrosis 54 Leber congenital amaurosis LCA 54 synapse formation 54 SSc 54 GIST 54 lymphoid tissue 54 pneumococcal meningitis 54 alpha synuclein 54 CFTR gene 54 motor neuron degeneration 54 claudin 54 Wnt1 54 miRNA 54 Duchenne Muscular Dystrophy DMD 54 myeloproliferative neoplasms 54 brain tumor 54 druggable targets 54 ErbB2 54 AGTR1 54 hypermethylated 54 non Hodgkin lymphomas 54 eosinophilic esophagitis 54 GATA3 54 BRCA1 gene 54 Neuregulin 1 54 genetic mutation 54 DLBCL 54 TRAIL induced apoptosis 54 thymic carcinoma 54 metastatic kidney 54 malignant gliomas 54 spontaneous mutations 54 SATB1 54 leukoencephalopathy 54 suppresses tumor 54 B Raf 54 microRNA 54 acute myelogenous 54 mutant proteins 54 JAK2 mutation 54 malignant fibrous histiocytoma 54 overexpressed 54 inherited neurological disorder 54 gastrointestinal cancers 54 carcinomas 54 MLL AF9 54 KSHV 54 KRAS oncogene 54 miRNA genes 54 gastrointestinal GI cancers 54 PTEN protein 54 metastatic disease 54 CXCL# 54 transplanted bone marrow 54 HNSCC 54 C#Y 54 lymphoid cells 54 TH# cells 54 chronic lymphocytic leukemia 54 beta catenin 54 somatic mutation 54 pituitary adenomas 54 hematologic disorders 54 hematologic malignancy 54 miR #b [002] 54 RPE# 54 Bcr Abl 54 pneumococci 54 HDAC6 54 acute myeloid 54 prostate cancers 54 HER2 overexpression 54 glioblastoma cells 54 pancreatic neuroendocrine 54 SOCS1 54 Janus kinase 54 tyrosine kinase inhibitor 54 N Myc 54 Fanconi Anemia 54 HER2 positive cancers 54 amyloid deposits 54 Tumours 54 ErbB 54 chromosomal abnormality 54 Ewing sarcoma rare 54 gene rearrangements 54 pro angiogenic 54 lung fibrosis 54 glioblastoma GBM 54 hematopoietic 54 adhesion molecule 54 leukemic 54 ovarian carcinoma 54 LKB1 54 eotaxin 54 brain tumor glioblastoma multiforme 54 airway hyperresponsiveness 54 Mantle Cell Lymphoma 54 Upregulation 54 Diffuse Intrinsic Pontine Glioma 54 neurofibromin 54 squamous cell carcinomas 54 Epstein Barr Virus EBV 54 Li Fraumeni 54 downregulation 54 metastatic tumor 54 hepatocellular carcinomas 54 tumorigenesis 54 transmembrane protein 54 calcineurin 54 Helicobacter 54 nasopharyngeal carcinoma 54 rhabdoid 54 parkin gene 54 VEGFR 54 MAPK pathway 54 estrogen receptor 54 Leber congenital amaurosis 54 Wnt pathway 54 Notch pathway 54 herpesviruses 54 FMR1 gene 54 Aβ 54 HMGA2 54 metastatic colon cancer 54 telomerase reverse transcriptase 54 ovarian tumor 54 polycystic kidneys 54 pyruvate kinase 54 pneumococcus 54 HHV 6 54 neural progenitor cells 54 K ras 54 imatinib resistance 54 demyelinating 53 PDGF receptor 53 lymphoproliferative disorders 53 squamous cell carcinoma 53 HLA identical 53 pediatric acute lymphoblastic 53 LRP5 53 hematological malignancy 53 p# protein 53 liver cancer 53 constitutively activated 53 Kaposi sarcoma 53 tumors GIST 53 chemokine receptor 53 granule cells 53 malignant prostate 53 myelination 53 cutaneous melanoma 53 Th# cells 53 glycogen synthase kinase 53 T1DM 53 CNVs 53 von Willebrand disease 53 Hedgehog signaling 53 Langerhans cell histiocytosis 53 CXCL5 53 noncoding RNAs 53 Gorlin syndrome 53 trypanosomes 53 thyroid tumors 53 selective inhibitor 53 imatinib Gleevec 53 Hodgkin lymphoma 53 sortilin 53 NRG1 53 miRNAs miR 53 commonly mutated genes 53 choriocarcinoma 53 soft tissue sarcomas 53 #q# [001] 53 tumoral 53 missense mutation 53 GPC5 53 Synovial sarcoma 53 anti angiogenic therapy 53 RANKL 53 Spinal Muscular Atrophy SMA 53 ALK gene 53 miR #a [001] 53 peritoneal carcinomatosis 53 hamartomas 53 transgenic mouse models 53 recurrent glioblastoma multiforme GBM 53 maternally inherited 53 S. pyogenes 53 flavopiridol 53 osteopetrosis 53 ANCA associated 53 CD8 + 53 endocrine tumors 53 chromosomal rearrangements 53 myeloproliferative disease 53 GRK2 53 PKM2 53 somatic mutations 53 tumor regression 53 Metastasis 53 KRAS wild 53 lymphocytic 53 p#INK#a 53 Lrp5 53 Metastatic 53 tubulin polymerization 53 carbohydrate antigens 53 HLA B# 53 tumor suppressor 53 non Hodgkin lymphoma 53 hematopoetic stem cells 53 PI3 kinase 53 Vpu 53 retinal degeneration 53 squamous cell 53 Cockayne syndrome 53 anticancer therapies 53 dystrophin 53 p# mutation 53 distant metastasis 53 allergic asthma 53 anti angiogenic drugs 53 cell signaling pathways 53 DHFR 53 mycobacterium 53 Tumors 53 Hutchinson Gilford progeria 53 mammary cancers 53 differentiated thyroid 53 CDK8 53 nonmetastatic 53 syngeneic 53 epigenetic modification 53 type 1diabetes 53 xenograft tumors 53 germline mutations 53 BRCA deficient 53 retinoblastoma Rb 53 Streptococcus pneumoniae 53 granzyme B 53 susceptibility gene 53 Chronic Myeloid Leukemia 53 Cowden syndrome 53 relapsed leukemia 53 ASDs 53 leukaemic stem cells 53 C1q 53 melatonin receptor 53 microglial cells 53 Non Hodgkin Lymphoma 53 cell lymphoma 53 Malignant mesothelioma 53 targeting CD# 53 SGK1 53 squamous cell cancers 53 TGF β1 53 transgene expression 53 colon tumors 53 retrovirus 53 invasive ductal carcinoma 53 progranulin 53 TTR amyloidosis 53 tumor metastases 53 CK2 53 chromosomal abnormalities 53 VEGF receptor 53 precursor lesions 53 Hutchinson Gilford Progeria Syndrome 53 Hepatocellular Carcinoma HCC 53 non metastatic osteosarcoma 53 histologies 53 enzymatic activity 53 small molecule inhibitors 53 bleomycin 53 cyclin dependent kinase 53 cilengitide 53 NSCLC tumors 53 H. pylori infection 53 meningiomas 53 acute leukemia AML 53 unmutated 53 HPV# 53 relapsed ALL 53 ERBB2 53 overexpressing 53 neutralizing antibody 53 TACE 53 Carcinoid tumors 53 apoE4 53 cyclin dependent kinases 53 Acute Myeloid Leukaemia AML 53 stem glioma 53 progeria 53 trisomy 53 p# [001] 53 anaplastic lymphoma kinase 53 MLL2 53 HOX genes 53 oral squamous cell 53 prostate cancer CaP 53 #q#.# [001] 53 ERK signaling 53 Bcl xL 53 Myelodysplastic Syndrome 53 Acute myeloid leukemia 53 Ewing sarcoma bone 53 sCJD 53 bone metastasis 53 Fas ligand 53 carcinogenesis 53 Dpp 53 supratentorial 53 ApoE 53 metastatic malignant 53 CCR2 53 breast cancer subtypes 53 induce apoptosis 53 p# MAP kinase 53 VZV 53 genotoxic stress 53 idiopathic myelofibrosis 53 alpha folate receptor 53 miR 53 apoE 53 carcinoid tumor 53 pRb 53 autoimmunity 53 genetic mutations 53 NSCLC 53 PI3K Akt 53 evolutionarily conserved 53 5q deletion 53 imatinib Gleevec ® 53 angiogenesis inhibitor 53 TNF α 53 Alport syndrome 53 telomere dysfunction 53 myelodysplastic syndrome 53 nonmelanoma skin cancers 53 primary cilia 53 CYT# potent vascular disrupting 53 MMP9 53 mutant huntingtin 53 Neurofibromatosis type 53 HER2 protein 53 P. gingivalis 53 Hodgkin Disease 53 ERCC1 53 Fragile X syndrome 53 follistatin 53 oncoproteins 53 promoter hypermethylation 53 osteoclast 53 juvenile idiopathic arthritis JIA 53 invasive breast cancer 53 FGFR3 53 hypoxia inducible factor 53 neurite outgrowth 53 chemoresistant 53 receptor CD# 53 cervical carcinoma 53 β catenin 53 bladder tumors 53 malignant mesothelioma 53 IGF IR 53 GPR# [002] 53 premalignant lesions 53 Annamycin 53 epigenetically 53 molecularly targeted 53 isoforms 53 nephrotic syndrome 53 multiple myeloma MM